Patents by Inventor Gerald L. Chrisope
Gerald L. Chrisope has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20040161480Abstract: A compound and method of using such compound is disclosed that, when administered to an animal, is capable of arresting the inflammatory response in affected tissues and facilitates the repair and maintenance of damaged tissues in the joints of vertebrates. The combination of natural physiological metabolites and herbal phytochemicals is used to treat connective tissue diseases, the composition preferably orally administered. One embodiment of the composition includes chondroitin sulfate and glucosamine that, when ingested by a vertebrate, suppresses the degradation of connective tissue by an autoimmune response. A preferred composition of the present invention includes a palatability agent, an herbal phytochemical, and a metabolic precursor that synergistically acts to increase blood circulation, thereby enhancing transport of the phytochemical and metabolic precursors to an affected site whereby deleterious inflammatory byproducts are removed.Type: ApplicationFiled: February 9, 2004Publication date: August 19, 2004Applicant: In Clover, Inc.Inventors: Rebecca Rose, Gerald L. Chrisope
-
Patent number: 6709682Abstract: A compound and method of using such compound is disclosed that, when administered to an animal, is capable of arresting the inflammatory response in affected tissues and facilitates the repair and maintenance of damaged tissues in the joints of vertebrates. The combination of natural physiological metabolites and herbal phytochemicals is used to treat connective tissue diseases, the composition preferably orally administered. One embodiment of the composition includes chondroitin sulfate and glucosamine that, when ingested by a vertebrate, suppresses the degradation of connective tissue by an autoimmune response. A preferred composition of the present invention includes a palatability agent, an herbal phytochemical, and a metabolic precursor that synergistically acts to increase blood circulation, thereby enhancing transport of the phytochemical and metabolic precursors to an affected site whereby deleterious inflammatory byproducts are removed.Type: GrantFiled: January 8, 2002Date of Patent: March 23, 2004Assignee: In Clover, Inc.Inventors: Rebecca Rose, Gerald L. Chrisope
-
Patent number: 6468526Abstract: Disclosed are novel isolated strains of bacteria of the genus Lactobacillus which are useful in a vaginal medicant. Also disclosed are medicants containing such Lactobacilli, a novel preservation matrix for microorganisms, a method for preserving microbial cells within a medicant, and methods for preventing and treating vaginal and gastrointestinal infections.Type: GrantFiled: December 21, 2001Date of Patent: October 22, 2002Assignee: GyneLogix, Inc.Inventor: Gerald L. Chrisope
-
Publication number: 20020090365Abstract: Disclosed are novel isolated strains of bacteria of the genus Lactobacillus which are useful in a vaginal medicant. Also disclosed are medicants containing such Lactobacilli, a novel preservation matrix for microorganisms, a method for preserving microbial cells within a medicant, and methods for preventing and treating vaginal and gastrointestinal infections.Type: ApplicationFiled: December 21, 2001Publication date: July 11, 2002Applicant: GyneLogix, Inc.Inventor: Gerald L. Chrisope
-
Publication number: 20020064568Abstract: A compound and method of using such compound is disclosed that, when administered to an animal, is capable of arresting the inflammatory response in affected tissues and facilitates the repair and maintenance of damaged tissues in the joints of vertebrates. The combination of natural physiological metabolites and herbal phytochemicals is used to treat connective tissue diseases, the composition preferably orally administered. One embodiment of the composition includes chondroitin sulfate and glucosamine that, when ingested by a vertebrate, suppresses the degradation of connective tissue by an autoimmune response. A preferred composition of the present invention includes a palatability agent, an herbal phytochemical, and a metabolic precursor that synergistically acts to increase blood circulation, thereby enhancing transport of the phytochemical and metabolic precursors to an affected site whereby deleterious inflammatory byproducts are removed.Type: ApplicationFiled: January 8, 2002Publication date: May 30, 2002Applicant: Clover, Inc.Inventors: Rebecca Rose, Gerald L. Chrisope
-
Patent number: 6372209Abstract: Disclosed are novel isolated strains of bacteria of the genus Lactobacillus which are useful in a vaginal medicant. Also disclosed are medicants containing such Lactobacilli, a novel preservation matrix for microorganisms, a method for preserving microbial cells within a medicant, and methods for preventing and treating vaginal and gastrointestinal infections.Type: GrantFiled: January 5, 2000Date of Patent: April 16, 2002Assignee: Gyne Logix, Inc.Inventor: Gerald L. Chrisope
-
Patent number: 6344220Abstract: A compound and method of using such compound is disclosed that, when administered to an animal, is capable of arresting the inflammatory response in affected tissues and facilitates the repair and maintenance of damaged tissues in the joints of vertebrates. The combination of natural physiological metabolites and herbal phytochemicals is used to treat connective tissue diseases, the composition preferably orally administered. One embodiment of the composition includes chondroitin sulfate and glucosamine that, when ingested by a vertebrate, suppresses the degradation of connective tissue by an autoimmune response. A preferred composition of the present invention includes a palatability agent, an herbal phytochemical, and a metabolic precursor that synergistically acts to increase blood circulation, thereby enhancing transport of the phytochemical and metabolic precursors to an affected site whereby deleterious inflammatory byproducts are removed.Type: GrantFiled: June 28, 1999Date of Patent: February 5, 2002Assignee: In Clover, Inc.Inventors: Rebecca Rose, Gerald L. Chrisope
-
Patent number: 6093394Abstract: Disclosed are novel isolated strains of bacteria of the genus Lactobacillus which are useful in a vaginal medicant. Also disclosed are medicants containing such Lactobacilli, a novel preservation matrix for microorganisms, a method for preserving microbial cells within a medicant, and methods for preventing and treating vaginal and gastrointestinal infections.Type: GrantFiled: April 11, 1997Date of Patent: July 25, 2000Assignee: GyneLogix, Inc.Inventor: Gerald L. Chrisope
-
Patent number: 5916565Abstract: A composition and method of use is disclosed that, when administered to an animal, is capable of arresting the inflammatory response in affected tissues and facilitates the repair and maintenance of damaged tissues in the joints of vertebrates. The combination of natural physiological metabolites and herbal phytochemicals is used to treat connective tissue diseases, the composition is preferably orally administered. One embodiment of the composition includes chondroitin sulfate and glucosamine that, when ingested by a vertebrate, suppresses the degradation of connective tissue by an autoimmune response. A composition of the present invention includes a palatability agent, an herbal phytochemical, and a metabolic precursor that act to increase blood circulation, thereby enhancing transport of the phytochemical and metabolic precursors to an affected site whereby deleterious inflammatory byproducts are removed.Type: GrantFiled: March 7, 1997Date of Patent: June 29, 1999Assignee: In Clover, Inc.Inventors: Rebecca Rose, Gerald L. Chrisope
-
Patent number: 5279964Abstract: The present invention is directed to an inoculation device including an easily manipulated handle together with microorganisms associated with a device for transferring and storing for extending periods stabilized, known microorganisms. This device is particularly useful in testing standard laboratory culture media. This device is easily produced by associating known microorganisms, either alone or together with a binding agent and other biologically acceptable additives and preservatives, with the sample transfer portion of the inoculation device. When substantially all of the water is removed from an inoculation device, including known microorganisms, the microbial containing device is storable for extended periods under sterile, dry conditions substantially free of water.Type: GrantFiled: November 8, 1991Date of Patent: January 18, 1994Assignee: Chrisope Technologies, Inc.Inventor: Gerald L. Chrisope
-
Patent number: 5155039Abstract: The present invention is directed to systems and methods for preserving, transporting, storing, re-hydrating and delivering viable micro-organisms. More particularly, the present invention is directed to a kit and method for preserving and storing dried, microbiological organisms and for re-hydrating and delivering specific and reproducible numbers of viable organisms therefrom. The kit and method of the present invention provides the capability to deliver a known quantity of rehydrated micro-organisms as a single, total dose of cells without the inaccuracies and safety hazards associated with standard needle, syringe or pipette transfer systems. The kit includes first and second vial and cap combinations, the first carrying the dried organisms in a dry, biologically inert atmosphere, the second carrying a pre-measured quantity of re-hydrating fluid. A quantitative number of selected microbiological organisms are dried under mild conditions, i.e.Type: GrantFiled: July 22, 1991Date of Patent: October 13, 1992Assignee: Chrisope Technologies, Inc.Inventors: Gerald L. Chrisope, Nell C. Roberts
-
Patent number: 4458019Abstract: This invention is directed to a method and system of obtaining a culture and placing the culture in a gaseous environment for transporting and incubating the culture. The method and system includes a fixed or portable small cylinder of a desired gaseous mixture, a nozzle secured to the outlet valve of the cylinder, a plurality of different sized zip-lock bags and a plurality of petri dishes or an equivalent type means for growing a culture.Type: GrantFiled: April 5, 1982Date of Patent: July 3, 1984Inventor: Gerald L. Chrisope